Immunoassay Market is Expected to Reach a Valuation of USD 45.78 Billion By 2032, Thriving at a CAGR of 5% from 2022 to 2032 | FMI Study

The immunoassay market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022

The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors that have shaped the growth dynamics are the advent of covid-19, the geriatric population, and rising awareness around health

With the environment changing and climate change-based diseases and viruses growing in the urban and rural areas, the demand for vaccines is on a rise. The immunoassay market survey explains that the tests of the effectiveness of these vaccines are conducted through immunoassays tests that include the strength of antibodies in the immune system, fueling the sales of immunoassay testing kits.

Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15437

Rising awareness, government research and development programs, and covid-19’s spread has collectively flourished the demand for the antibodies testing systems. Hence, it has expanded the immunoassay market share in the global market

This fueled the market’s growth prospects and brought opportunities for the new medical and healthcare market players to come up with the latest technology and integrate it with immunoassay technology. Furthermore, the breakdown of the third covid-19 wave has partially slowed down the growth of the market as the spread is at lower levels

Key Takeaways from Market Study

• The Immunoassay market is expected to increase with a market share of 35.0% in North America.
• Asia Pacific is expected to account for 30% market share during the assessment year.
• By product, reagents and kits accounted for 60% share of total revenue generated of the immunoassay market globally and is anticipated to hold the highest share by 2032, owing to the cost-effective products, fueling the overall sales of immunoassay testing instrument
• EIA/ELISA technology gains the highest traction in the market by technology with a market share of 60% and its growth owing to higher use of it in reducing the assay time for immunoelectrophoretic and immunodiffusion while providing accurate and quantitive results.

Immunoassay Market in North America is Constantly Evolving

The largest market share of 35% in 2022 is expected to hold the same position throughout the forecast period, according to the immunoassay market demand analysis. The rise in demand can be attributed to an increase in cancer incidence as well as the ease of access to technologically advanced diagnostic techniques. Outbreaks of infectious diseases are becoming more common in the region.

Expand operations in the future – To get requisite details, ask for a custom report@ https://www.futuremarketinsights.com/customization-available/rep-gb-15437

“Immunoassay market analysis displays the higher growth prospects due to the higher awareness of the new viruses and diseases that demand for higher antibodies in the body. An immunoassay test gives you information about the antibodies present in the body for any specific virus or disease spread by it. Demand for immunoassay tests rises as the hospitals, clinics, and research and development centers established by the government are consuming the most from the market” says a Future Market Insights analyst.

Competitive Landscape

New market research report on immunoassay defines the market space as a younger space where there is a space for innovation and technology. The defining factors key players have been the ability to deliver effective and accurate results while making the product more logistics friendly and easy to use.

• Siemens Healthineers has introduced its latest and revised fully automated immunoassay platforms and a comprehensive and disease-specific chart in excess of 100 tests. This enhanced productivity and efficiency while delivering accurate and faster results.
• Biomerieux, with more than 26000 immunoassay systems globally has introduced its R7D programs that covers high medical value applications, increased automation and decentralized testing, flourishing the sales of immunoassay platforms.
• Abbott Laboratories focuses on chia technology and offers an automatic immunoassay analyzer named Abbott prism, delivers effectiveness and enhances productivity.

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global Immunoassay market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on Application (Food, Beverage, Pharmaceuticals, Other (Applications), Form (Natural Immunoassay, Synthetic Immunoassay), Region (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA)

Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/15437

Immunoassay Market by Category

By Product, Immunoassay Market is segmented as:

• Reagents & Kits
• Analyzers/Instruments
  • Open-ended Systems
  • Closed-ended Systems
• Software & Services

By Technology, Immunoassay Market is segmented as:

• Radioimmunoassay (RIA)
• Enzyme Immunoassays (EIA)Rapid Test
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
• Others

By End-use, Immunoassay Market is segmented as:

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases

By Application, Immunoassay Market is segmented as:

• Hospitals
• Blood Banks
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others

By Form, Immunoassay Market is segmented as:

• Natural Immunoassay
• Synthetic Immunoassay

More Trending Reports by Future Market Research :

Breast Cancer Drug Market Analysis : The global breast cancer drug market size is expected to be valued at US$ 10,637.42 Million in 2022.

Humanized Mouse Model Market Trends : The global humanized mouse model market is expected to be valued at US$ 92.5 Million in 2022. Throughout the decade spanning 2022-2032

Medical Cleaning Devices Market Growth : The global Medical cleaning devices market is expected to reach a market valuation of US$ 21.5 Billion by the year 2022.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs